Ronna Romney
About Ronna E. Romney
Ronna E. Romney is Vice-Chair of the Board at Molina Healthcare (MOH), a director since 2003 and currently Chair of the Corporate Governance & Nominating Committee and a member of the Compensation Committee . She is 81 years old and holds a B.A. from Oakland University; prior roles include Lead Independent Director (2003–2017) and director of Molina Healthcare of Michigan (1999–2004), with extensive U.S. federal public policy experience and board governance credentials .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Molina Healthcare, Inc. | Lead Independent Director | 2003–2017 | Led independent board oversight prior to elimination of role in 2017 |
| Molina Healthcare of Michigan | Director | 1999–2004 | Subsidiary board service |
| President’s Commission on White House Fellowships | Chairwoman | 1989–1993 | Appointed by President George H.W. Bush |
| President’s Commission on Presidential Scholars | Chairwoman | 1985–1989 | Appointed by President Ronald Reagan |
| President’s National Advisory Council on Adult Education | Commissioner | 1982–1985 | Appointed by President Ronald Reagan |
| Republican National Committee (Michigan) | Member | 1984–1992 | State party leadership |
| Political/News Media | Commentator (Radio/TV) | 1992–1998 | Public affairs communications |
| U.S. Senate (Michigan) | Candidate | 1996 | Statewide campaign |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Park-Ohio Holdings Corp. (public) | Director | Since 2001 | Logistics and manufacturing; ongoing public board service |
Board Governance
- Current MOH roles: Vice-Chair of the Board; Chair, Corporate Governance & Nominating Committee; Member, Compensation Committee .
- Committee independence: All CG&N and Compensation members (including Romney) are independent under NYSE standards; Board majority is independent per Governance Guidelines .
- Board leadership: Independent Chairman (Dale B. Wolf); Romney serves as Vice-Chair assisting the Chair; roles are split from CEO .
- Meetings and attendance (2024): Board (10), Audit (9), CG&N (3), Compensation (7), Compliance & Quality (3), Finance (8); each current director attended ≥75% of applicable meetings and the 2024 annual meeting .
- Executive sessions: Independent directors customarily meet in executive session at each regularly scheduled in-person Board meeting (usually four per year) .
Shareholder voting (2025 Annual Meeting):
- Director election (Romney): Votes For 40,038,425; Against 4,742,279; Abstentions 189,214; Broker Non-Votes 1,848,771 .
- Say-on-Pay (advisory): For 18,249,700; Against 26,653,672; Abstentions 66,546; Broker Non-Votes 1,848,771 .
Fixed Compensation
| Component (2024) | Amount |
|---|---|
| Annual cash retainer (non-exec directors) | $125,000 |
| Vice-Chair of the Board fee | $30,000 |
| CG&N Committee chair fee | $22,500 |
| Compensation Committee member fee | $12,500 |
| Per diem for non-ordinary course Board/committee work | $1,000/day |
| Total cash paid to Romney (2024) | $190,000 |
Notes:
- Additional committee fee schedule: Audit Chair $32,500; Audit member $15,000; Compensation Chair $22,500; Compensation member $12,500; CG&N Chair $22,500; CG&N member $12,500; Compliance & Quality Chair $22,500; member $12,500; Finance Chair $22,500; member $15,000 .
- Non-employee Chairman fee moved to $255,000 effective Q4 2024 (context for program design) .
Performance Compensation
| Equity Award Structure (2024) | Details |
|---|---|
| Annual equity value (non-employee directors) | $220,000 (restricted stock), granted $55,000 per quarter; vests immediately |
| Q1 2024 grant date closing price | $361.31 (Jan 1, 2024) |
| Q2 2024 grant date closing price | $404.20 (Apr 1, 2024) |
| Q3 2024 grant date closing price | $292.16 (Jul 1, 2024) |
| Q4 2024 grant date closing price | $341.91 (Oct 1, 2024) |
| Stock awards reported for Romney (aggregate 2024) | $219,864 |
| Options outstanding (directors) | None; no stock options or unvested stock awards outstanding as of Dec 31, 2024 |
| Non-employee director annual limit | Cash fees + equity awards capped at $750,000 in total value; higher cap allowed for non-exec Chair by independent directors |
Notes:
- Director equity is not tied to performance metrics; awards are full-value restricted stock vesting immediately each quarter .
Other Directorships & Interlocks
| Item | Detail |
|---|---|
| Other current public board | Park-Ohio Holdings Corp., Director since 2001 |
| Compensation committee interlocks (2024) | None; no interlocks under SEC rules |
| Compensation consultant | FW Cook engaged May 2024; committee determined independence; advises on exec and director pay |
Expertise & Qualifications
- Governance and executive compensation expertise; prior Compensation Committee chair experience; extensive government affairs background (presidential commissions; RNC) .
- Honors: NACD Top 100 Directors (2015); WomenInc. Most Influential Corporate Board Directors (2019, 2023) .
- Vice-Chair responsibilities reflect board leadership and governance acumen .
Equity Ownership
| Holder | Shares Beneficially Owned | % Outstanding | Notes |
|---|---|---|---|
| Ronna E. Romney | 17,483 | <1% (denoted by “*”) | All shares held by Ronna Romney Revocable Trust |
| Shares outstanding (as of Mar 7, 2025) | 54,699,859 | — | Company total outstanding for percentage context |
| Pledging/Hedging | Pledging prohibited; none of the directors/officers had pledges; hedging prohibited for insiders | — | Policy-based alignment |
| Stock ownership guidelines (directors) | Minimum 5x annual cash retainer; must retain 50% of net settled shares until in compliance; all non-employee directors were in compliance as of Dec 31, 2024 | — | Alignment requirement |
Governance Assessment
-
Strengths:
- Longstanding independent leadership: Vice-Chair; prior Lead Independent Director (2003–2017); Chair of Corporate Governance & Nominating Committee; member of Compensation Committee .
- Formal ownership alignment: 5x cash retainer guideline; all non-employee directors in compliance; no pledging/hedging allowed .
- Active board practices: regular executive sessions; independent chair structure; strong meeting cadence; Romney met ≥75% attendance threshold (company-wide) and attended 2024 annual meeting .
-
Risk indicators and potential red flags:
- Related-party transaction: Romney’s son employed by MOH with ~$153,000 base salary and a $39,589 2024 bonus; reviewed and ratified under the company’s related person transaction policy (threshold >$120,000) .
- 2025 Say-on-Pay failed (Against 26.65M vs For 18.25M), signaling investor dissatisfaction with executive pay; as a Compensation Committee member, heightened scrutiny of the committee’s responsiveness is likely .
- Director election support: Romney received 40.0M For vs 4.74M Against; while elected, opposition magnitude is a sentiment datum for engagement focus .
-
Structural safeguards:
- Director equity capped at $750,000 total value (incl. fees) per year; no option repricing; no “liberal” CIC or single-trigger vesting; dividend restrictions on unvested awards per 2025 Plan governance highlights .
- Independent compensation consultant (FW Cook) engaged, with independence affirmed .
Overall implication for investors: Romney brings deep governance and public policy expertise and continuity in board leadership, with clear alignment mechanisms (ownership guidelines, prohibitions on pledging/hedging). The related-party employment of her son is a monitored and ratified exception under policy, and the failed 2025 Say-on-Pay increases the onus on the Compensation Committee (of which she is a member) to demonstrate responsiveness to shareholder feedback in the next CD&A and program design .
Best AI for Equity Research
Performance on expert-authored financial analysis tasks
Best AI for Equity Research
Performance on expert-authored financial analysis tasks